Hengartner, Michael P.
Kalaidos University of Applied Sciences
20 papers on CoChatORCID 0000-0002-2956-2969
Most cited papers
- Verified
The serotonin theory of depression: a systematic umbrella review of the evidence
Moncrieff, J., Cooper, R. E., Stockmann, T., Amendola, S., Hengartner, M. P., & Horowitz, M. A. (2023) · Molecular Psychiatry
Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression
Cited by 960
- Verified
Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression.
Hengartner, M. P., & Plöderl, M. (2022) · BMJ Evidence-Based Medicine
Treatment of Major DepressionHealth Systems, Economic Evaluations, Quality of Life
Cited by 114
- Verified
Sub-clinical psychosis symptoms in young adults are risk factors for subsequent common mental disorders
Rössler, W., Hengartner, M. P., Ajdacic-Gross, V., Haker, H., Gamma, A., & Angst, J. (2011) · Schizophrenia Research
Schizophrenia research and treatmentMental Health Treatment and Access
Cited by 103
- Verified
Childhood adversity in association with personality disorder dimensions: New findings in an old debate
Hengartner, M. P., Ajdacic-Gross, V., Rodgers, S., Müller, M., & Rössler, W. (2013) · European Psychiatry
Personality Disorders and PsychopathologyChild Abuse and Trauma
Cited by 90
- Verified
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data
Horowitz, M. A., Framer, A., Hengartner, M. P., Sørensen, A., & Taylor, D. (2023) · CNS Drugs
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 76
- Verified
Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum
Hengartner, M. P., Schulthess, L., Sorensen, A., & Framer, A. (2020) · Therapeutic Advances in Psychopharmacology
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 74
- Verified
How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding
Hengartner, M. P. (2020) · Therapeutic Advances in Psychopharmacology
Treatment of Major DepressionMental Health Treatment and Access
Cited by 72
- Verified
Linking substance use with symptoms of subclinical psychosis in a community cohort over 30 years
Rössler, W., Hengartner, M. P., Angst, J., & Ajdacic‐Gross, V. (2012) · Addiction
Schizophrenia research and treatmentCannabis and Cannabinoid Research
Cited by 67
- Verified
Occupational functioning and work impairment in association with personality disorder trait-scores
Hengartner, M. P., Müller, M., Rodgers, S., Rössler, W., & Ajdacic-Gross, V. (2014) · Social Psychiatry and Psychiatric Epidemiology
Personality Disorders and PsychopathologyPersonality Traits and Psychology
Cited by 60
- Verified
Interpersonal functioning deficits in association with DSM-IV personality disorder dimensions
Hengartner, M. P., Müller, M., Rodgers, S., Rössler, W., & Ajdacic-Gross, V. (2014) · Social Psychiatry and Psychiatric Epidemiology
Personality Disorders and PsychopathologyPersonality Traits and Psychology
Cited by 56
- Verified
Antidepressant withdrawal – the tide is finally turning
Hengartner, M. P., Davies, J., & Read, J. (2020) · Epidemiology and Psychiatric Sciences
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 48
- Verified
The Role of Psychopathological and Personality Covariates in Orgasmic Difficulties: A Prospective Longitudinal Evaluation in a Cohort of Women from Age 30 to 50
Leeners, B., Hengartner, M. P., Rössler, W., Ajdacic-Gross, V., & Angst, J. (2014) · The Journal of Sexual Medicine
Sexual function and dysfunction studiesSexuality, Behavior, and Technology
Cited by 46
- Verified · note
Subclinical psychosis syndromes in the general population: results from a large-scale epidemiological survey among residents of the canton of Zurich, Switzerland
Rössler, W., Ajdacic-Gross, V., Haker, H., Rodgers, S., Müller, M., & Hengartner, M. P. (2015) · Epidemiology and Psychiatric Sciences
Schizophrenia research and treatmentMental Health Treatment and Access
Cited by 36
- Verified
Assessing sub-clinical psychosis phenotypes in the general population - A multidimensional approach
Rössler, W., Ajdacic-Gross, V., Müller, M., Rodgers, S., Haker, H., & Hengartner, M. P. (2015) · Schizophrenia Research
Schizophrenia research and treatmentMental Health and Psychiatry
Cited by 35
- Verified
Prevalence, trends, and individual patterns of long-term antidepressant medication use in the adult Swiss general population
Amrein, M. A., Hengartner, M. P., Näpflin, M., Farcher, R., & Huber, C. A. (2023) · European Journal of Clinical Pharmacology
Mental Health Treatment and AccessTreatment of Major Depression
Cited by 23
- Verified
Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA
Hengartner, M. P., & Plöderl, M. (2021) · Therapeutic Advances in Psychopharmacology
Treatment of Major DepressionStatistical Methods in Clinical Trials
Cited by 23
- Verified
Sex differences in sub-clinical psychosis—Results from a community study over 30years
Rössler, W., Hengartner, M. P., Ajdacic-Gross, V., Haker, H., & Angst, J. (2012) · Schizophrenia Research
Schizophrenia research and treatmentPsychopathy, Forensic Psychiatry, Sexual Offending
Cited by 16
- Verified
False Beliefs in Academic Psychiatry: The Case of Antidepressant Drugs
Hengartner, M. P., & Plöderl, M. (2018) · Ethical Human Psychology and Psychiatry
Treatment of Major DepressionPain Management and Placebo Effect
Cited by 10
- Verified
Post-acute withdrawal syndrome (PAWS) after stopping antidepressants: a systematic review with meta-narrative synthesis
Rennwald, A., & Hengartner, M. P. (2025) · Epidemiology and Psychiatric Sciences
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 8
- Verified
Long-Term Antidepressant Use and Dementia Risk: A Propensity Score-Matched Study of Swiss Older Adults, with an Anticholinergic-Specific Analysis
Amrein, M. A., Hengartner, M. P., Näpflin, M., Farcher, R., & Huber, C. A. (2026) · Drugs - Real World Outcomes
Dementia and Cognitive Impairment ResearchPharmaceutical Practices and Patient Outcomes
Cited by 0
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free